3-Azetidinylpiperidine-4-alkylidenemalononitrile and Related Building Blocks
Organic Letters · 26.06.2026 · 28 (25) · 8234-8239
DOI: 10.1021/acs.orglett.6c02310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, online erschienen am 11.06.2026. Verfasst von Juan M Sanfiel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States. Hauptthemen laut MEDLINE: Azetidines, Nitriles, Piperidines, Cyclobutanes. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, University of Minnesota, U.S. Department of Health and Human Services.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States.
- Department of Chemistry, University of Florida, Gainesville Florida 32611, United States.
ORCID-Profile: Jan-Niklas Boyn, Alexander J Grenning
Förderung
- NIGMS NIH HHS
- University of Minnesota
- U.S. Department of Health and Human Services
Zitieren
APA
Sanfiel, J. M., McCabe, A. T., Nilova, A., Graf, S. L., Boyn, J. N., & Grenning, A. J. (2026). 3-Azetidinylpiperidine-4-alkylidenemalononitrile and Related Building Blocks. Organic Letters, 28(25), 8234-8239. https://doi.org/10.1021/acs.orglett.6c02310
Vancouver
Sanfiel JM, McCabe AT, Nilova A, Graf SL, Boyn JN, Grenning AJ. 3-Azetidinylpiperidine-4-alkylidenemalononitrile and Related Building Blocks. Organic Letters. 2026;28(25):8234-8239. doi:10.1021/acs.orglett.6c02310
BibTeX
@article{Sanfiel2026,
author = {Sanfiel, Juan M and McCabe, Andrew T and Nilova, Aleksandra and Graf, Samuel L and Boyn, Jan-Niklas and Grenning, Alexander J},
title = {3-Azetidinylpiperidine-4-alkylidenemalononitrile and Related Building Blocks},
journal = {Organic Letters},
year = {2026},
volume = {28},
number = {25},
pages = {8234--8239},
doi = {10.1021/acs.orglett.6c02310}
}
EUVIMED